liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Phosphocholine-Modified Macromolecules and Canonical Nicotinic Agonists Inhibit ATP-Induced IL-1 beta Release
University of Giessen, Germany.
University of Giessen, Germany.
University of Giessen, Germany.
University of Giessen, Germany; University of Giessen, Germany.
Show others and affiliations
2015 (English)In: Journal of Immunology, ISSN 0022-1767, E-ISSN 1550-6606, Vol. 195, no 5, 2325-2334 p.Article in journal (Refereed) Published
Abstract [en]

IL-1 beta is a potent proinflammatory cytokine of the innate immune system that is involved in host defense against infection. However, increased production of IL-1 beta plays a pathogenic role in various inflammatory diseases, such as rheumatoid arthritis, gout, sepsis, stroke, and transplant rejection. To prevent detrimental collateral damage, IL-1 beta release is tightly controlled and typically requires two consecutive danger signals. LPS from Gram-negative bacteria is a prototypical first signal inducing pro-IL-1 beta synthesis, whereas extracellular ATP is a typical second signal sensed by the ATP receptor P2X7 that triggers activation of the NLRP3-containing inflammasome, proteolytic cleavage of pro-IL-1 beta by caspase-1, and release of mature IL-1 beta. Mechanisms controlling IL-1 beta release, even in the presence of both danger signals, are needed to protect from collateral damage and are of therapeutic interest. In this article, we show that acetylcholine, choline, phosphocholine, phosphocholine-modified LPS from Haemophilus influenzae, and phosphocholine-modified protein efficiently inhibit ATP-mediated IL-1 beta release in human and rat monocytes via nicotinic acetylcholine receptors containing subunits alpha 7, alpha 9, and/or alpha 10. Of note, we identify receptors for phosphocholine-modified macromolecules that are synthesized by microbes and eukaryotic parasites and are well-known modulators of the immune system. Our data suggest that an endogenous anti-inflammatory cholinergic control mechanism effectively controls ATP-mediated release of IL-1 beta and that the same mechanism is used by symbionts and misused by parasites to evade innate immune responses of the host.

Place, publisher, year, edition, pages
AMER ASSOC IMMUNOLOGISTS , 2015. Vol. 195, no 5, 2325-2334 p.
National Category
Chemical Sciences
Identifiers
URN: urn:nbn:se:liu:diva-121432DOI: 10.4049/jimmunol.1400974ISI: 000360014200045PubMedID: 26202987OAI: oai:DiVA.org:liu-121432DiVA: diva2:855127
Note

Funding Agencies|University Medical Centre Giessen and Marburg; Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz of the State of Hesse (Nonneuronal Cholinergic Systems); German Research Foundation [GR 1094/6-1]

Available from: 2015-09-18 Created: 2015-09-18 Last updated: 2015-09-18

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Schweda, Elke
By organisation
ChemistryFaculty of Science & Engineering
In the same journal
Journal of Immunology
Chemical Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 38 hits
ReferencesLink to record
Permanent link

Direct link